Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01605
|
|||||
| Drug Name |
Taxifolin
|
|||||
| Synonyms |
TAXIFOLIN; (+)-Taxifolin; dihydroquercetin; Distylin; Taxifoliol; (2R,3R)-Dihydroquercetin; (+)-Dihydroquercetin; TAXIFOLIN-(+); Lavitol; Lariksin; taxifolin (dihydroquercetin); 3,5,7,3',4'-Pentahydroxyflavanone; UNII-9SOB9E3987; trans-Dihydroquercetin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; (+)-trans-Taxifolin; (2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE; (2R,3R)-3,3',4',5,7-Pentahydroxyflavanone
|
|||||
| Indication | Ovarian cancer [ICD11: 2C73] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H12O7
|
|||||
| Canonical SMILES |
C1=CC(=C(C=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
|
|||||
| InChI |
InChI=1S/C15H12O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,14-19,21H/t14-,15+/m0/s1
|
|||||
| InChIKey |
CXQWRCVTCMQVQX-LSDHHAIUSA-N
|
|||||
| CAS Number |
CAS 480-18-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 304.25 | Topological Polar Surface Area | 127 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
1.5
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:17948
|
|||||
| DT(s) Transporting This Drug | MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [2] | |
| References | ||||||
| 1 | Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer. 2008;60(6):800-9. | |||||
| 2 | Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp. Int J Pharm. 2009 Aug 13;378(1-2):1-8. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.